Free Trial

Astrana Health (NASDAQ:ASTH) Hits New 1-Year Low - Here's Why

Astrana Health logo with Medical background

Key Points

Error: One or more errors occurred.

Shares of Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) reached a new 52-week low during trading on Thursday . The stock traded as low as $21.36 and last traded at $21.81, with a volume of 343885 shares changing hands. The stock had previously closed at $22.32.

Astrana Health Stock Performance

The firm has a market cap of $1.22 billion, a P/E ratio of 30.29, a price-to-earnings-growth ratio of 0.82 and a beta of 0.85. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 0.54. The business's fifty day simple moving average is $24.44 and its 200-day simple moving average is $29.36.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). The firm had revenue of $620.39 million during the quarter, compared to the consensus estimate of $628.11 million. Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. Astrana Health's revenue was up 53.4% on a year-over-year basis. During the same period last year, the business earned $0.31 EPS. As a group, sell-side analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Institutional Investors Weigh In On Astrana Health

A number of large investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in shares of Astrana Health by 4.5% during the 1st quarter. Vanguard Group Inc. now owns 4,898,992 shares of the company's stock valued at $151,918,000 after purchasing an additional 213,033 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Astrana Health by 10.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company's stock valued at $32,968,000 after purchasing an additional 101,192 shares in the last quarter. 325 Capital LLC lifted its position in Astrana Health by 30.3% during the 4th quarter. 325 Capital LLC now owns 886,916 shares of the company's stock valued at $27,964,000 after acquiring an additional 206,009 shares during the period. SteelPeak Wealth LLC lifted its position in Astrana Health by 4.8% during the 1st quarter. SteelPeak Wealth LLC now owns 568,176 shares of the company's stock valued at $17,619,000 after acquiring an additional 26,192 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in Astrana Health by 6.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 499,529 shares of the company's stock valued at $15,490,000 after acquiring an additional 28,200 shares during the period. Institutional investors own 52.77% of the company's stock.

About Astrana Health

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astrana Health Right Now?

Before you consider Astrana Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.

While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines